Search research articles
Contact Us
Filters
Showing results (81-90 of 117) with videos related to
Page
of 12
Sort By:
Oncoimmunology
|
August 8, 2020
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Ieva Saulite, Desislava Ignatova, Yun-Tsan Chang, et al.
European Journal of Clinical Pharmacology
|
June 30, 2019
Correction to: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement
Jennifer L Goldman, Wen-Hung Chung, Brian R Lee, et al.
European Journal of Clinical Pharmacology
|
March 29, 2019
Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement
Jennifer L Goldman, Wen-Hung Chung, Brian R Lee, et al.
The British Journal of Dermatology
|
March 20, 2025
Evidence of Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation Induced by Extracorporeal Photopheresis in Patients with leukemic forms of cutaneous T cell lymphoma
Angelika Lackner, Teresa Burner, Marlene Brandner, et al.
Annals of Surgical Oncology
|
April 22, 2017
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma
Dagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Oncoimmunology
|
June 7, 2018
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma
Dagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Nature Communications
|
January 25, 2024
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides
Yun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, et al.
Cancer Cell
|
August 27, 2021
Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
Mario Mairhofer, Lea Kausche, Sabine Kaltenbrunner, et al.
EMBO Molecular Medicine
|
July 26, 2024
Dantrolene corrects cellular disease features of Darier disease and may be a novel treatment
Matthew Hunt, Nuoqi Wang, Naricha Pupinyo, et al.
The Journal of Allergy and Clinical Immunology
|
August 7, 2016
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
Thomas Werfel, Jean-Pierre Allam, Tilo Biedermann, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 117) with videos related to
Sort By:
Page
of 12
Oncoimmunology
|
August 8, 2020
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Ieva Saulite, Desislava Ignatova, Yun-Tsan Chang, et al.
European Journal of Clinical Pharmacology
|
June 30, 2019
Correction to: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement
Jennifer L Goldman, Wen-Hung Chung, Brian R Lee, et al.
European Journal of Clinical Pharmacology
|
March 29, 2019
Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement
Jennifer L Goldman, Wen-Hung Chung, Brian R Lee, et al.
The British Journal of Dermatology
|
March 20, 2025
Evidence of Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation Induced by Extracorporeal Photopheresis in Patients with leukemic forms of cutaneous T cell lymphoma
Angelika Lackner, Teresa Burner, Marlene Brandner, et al.
Annals of Surgical Oncology
|
April 22, 2017
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma
Dagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Oncoimmunology
|
June 7, 2018
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma
Dagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Nature Communications
|
January 25, 2024
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides
Yun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, et al.
Cancer Cell
|
August 27, 2021
Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
Mario Mairhofer, Lea Kausche, Sabine Kaltenbrunner, et al.
EMBO Molecular Medicine
|
July 26, 2024
Dantrolene corrects cellular disease features of Darier disease and may be a novel treatment
Matthew Hunt, Nuoqi Wang, Naricha Pupinyo, et al.
The Journal of Allergy and Clinical Immunology
|
August 7, 2016
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
Thomas Werfel, Jean-Pierre Allam, Tilo Biedermann, et al.
Page
of 12